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T hank you so very much for inviting me to deliver this keynote address. The big question mark in the title refers to whether we are going to get more or less respect in the future. Will we take 2 steps forward and 1 step back or 2 steps forward and more again? I also 
want to thank Aretha Franklin for her version of “Respect,” as it provides 
a motivating match for the theme of this keynote. Aretha was and is a true 
pioneer. She was the first woman inducted into the Rock and Roll Hall 
of Fame and continues to impress. When you look at pioneers, you come 
across 4 things that are particularly relevant today.
 First, pioneers take risks. Our chair, Sue Hudson, and AMWA took a risk 
inviting me; I think I might be the first non-US-based person in the his-
tory of AMWA to deliver the keynote address. I better not ruin it for anyone 
else! Second, pioneers get shot at. I may say things today that you don’t like 
or don’t agree with—that’s good. We’ll test some boundaries this morning 
and, today, you can shoot the messenger. Third, pioneers explore options.  
I am going to explore options that could help address 3 major challenges for 
our profession. And fourth, pioneers can make it easier for others. I truly 
hope that something comes from today that makes it easier for the next 
generation of medical communicators.
 If we want respect for our profession, we need to continue to find and 
support the pioneers in our profession. We’ve certainly had pioneers in the 
past who have helped our profession earn respect. To start, I want to pay 
homage to a few of AMWA’s pioneers (and I apologize in advance for not 
being able to list more). These pioneers took steps forward to advance our 
profession, even in rocky times. 
 In 1940, the pioneer was Harold Swanberg, who with 5 others (all MDs), 
founded the Mississippi Valley Medical Editors Association, which, as many 
of you know, evolved into AMWA in 1948. Harold must have known that you 
can’t respect something if you don’t know what “it” is. Harold realized that 
there was a body of knowledge about medical communication, and he took 
the step of establishing an organization to serve its needs.
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Editor’s note: We originally assigned a reporter to 
cover the Keynote Address, but Karen Woolley’s pre-
sentation was thought to be of such value that we 
made the decision to reprint it in full. The address is 
followed by a commentary written by the reporter, as 
well as comments from AMWA leadership. 
Dr Karen Woolley is the first AMWA keynote 
speaker in recent memory who is one of us: a 
medical writer. She’s internationally engaged 
in advancing our profession through teach-
ing, research, and advocacy for higher edu-
cational and ethical standards. Karen strode 
into the conference hotel’s ballroom accom-
panied by Aretha Franklin’s song “Respect,” 
then outlined 3 major problems facing medi-
cal writers: lack of evidence that we add value 
to our projects and are ethical; lack of a truly 
international approach to training; and iso-
lation from other stakeholders, particularly 
journal editors. For each problem, she sug-
gested actions that individual members can 
take, as well as actions that the profession can 
take. Her recommendations go far beyond 
denouncing ghostwriting! Karen received 
a long standing ovation followed by more 
than 20 minutes of questions, suggesting that 
AMWA members will be discussing her ideas 
for months to come. Don’t miss reading about 
them here.
—Faith Reidenbach, ELS
[ConferenCe Coverage]
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 In 1971, the pioneer was Eric W 
Martin. He became AMWA’s first 
non-MD President; he also pioneered 
the draft of the first Code of Ethics, 
which was approved in 1973. Ethics is 
certainly not a new issue for medical 
communicators, but it remains criti-
cal to our profession.
 In 1977, the pioneer was Virginia 
T. Eicholtz. Virginia was not the first 
woman to contribute to AMWA, but 
she was the first woman to serve as 
President.
 In 1978, the pioneer was Edith 
Schwager. Edie not only started the 
much-revered Dear Edie column, but 
by turning green at a smoke-filled 
AMWA meeting, she also helped 
AMWA take the first steps to being 
a nonsmoking organization. Like so 
many advances, this may not have 
been popular at the time, but it was 
the right thing to do 
 In 1979, the pioneers were Lottie 
B. Applewhite and Gerald McKee, who 
started the AMWA core certificate 
program at the 1979 AMWA Annual 
Meeting in Kansas City. This was 
another important step forward in 
getting respect for the body of knowl-
edge required by medical communi-
cators.
 In 2003, the pioneers were Cindy 
Hamilton and Mary Royer. These 
women are certainly not past being 
pioneers, but their past actions have 
advanced our profession. On behalf 
of an AMWA Taskforce, Cindy and 
Mary published the AMWA Position 
Statement on the Contributions 
of Medical Writers to Scientific 
Publications.1 This statement has 
served as a benchmark for other orga-
nizations and reinforces the legiti-
macy and ethics of our profession. 
 Just as our past pioneers faced 
challenges affecting respect for our 
profession, we now face challenges 
affecting respect for our profession. 
Today, I will identify 3 major chal-
lenges and suggest ways that we, 
as a profession, and you, as a medi-
cal communicator, might help solve 
them.
 The first challenge is that to some 
people, we may as well be peddling 
snake oil. Where is the hard evidence 
about the value and ethics of medical 
communicators? The second chal-
lenge is that we are facing new fron-
tiers. Medical communicators are 
appearing in all corners of the world; 
how can we ensure that we all offer 
value and ethics? The third challenge 
is that we can seem a little lonely. How 
can we reach out more effectively to 
those who need to hear our side of the 
story, such as medical journal editors 
and journalists? We need to overcome 
these 3 challenges to get more respect.
 Now I know, particularly in light of 
recent media and political pressure, 
that AMWA members have been ask-
ing AMWA: “Can we, as a profession, 
do anything?” “Can I, as an AMWA 
member, do anything?” By the end 
of this presentation, I want you to be 
able to say “yes” to both questions.
 So, in broad terms, what can we 
do? Well, we can do some things that 
make no real difference at all. We can 
worry. And worry we do; the prob-
lem is, all that worry gets us no closer 
to getting more respect. We can also 
react, when others say something 
good about us and when others say 
something bad about us. But again, 
that may or may not get us more 
respect. What we need to do is take 
control. I am now going to suggest 
ways in which we can take control 
over those 3 challenges affecting our 
profession.
Need for evideNce About the 
vAlue ANd ethics of MedicAl 
coMMuNicAtors
To address our first challenge, we need 
to investigate the value and ethics of 
our profession. Where is the evidence 
that we provide any value? Further, 
where is this evidence published so 
that those who might criticize us can 
read it? Most of the information we 
have on our value and ethics has been 
published in our association news-
letters and journals, which are rarely 
read by influential editors, journal-
ists, regulators, or politicians. How 
can these people really know about 
our value; how do they (or in fact we) 
really know that we can
•	 Save	time	for	authors,	peer	review-
ers, editors, or regulators?
•	 Enhance	the	quality	of	documents?
•	 Reduce	costs	by	doing	things	the	
right way the first time?
•	 Reduce	the	risk	of	important	data	
not being published?
 In addition to our need for pub-
lished evidence on the value we pro-
vide, where is the evidence on our 
ethics? We know from the last survey 
of AMWA members that ethics is “by 
far the greatest concern” (your num-
ber-1 issue), and these issues arise on 
the AMWA listserve. For example, one 
AMWA member asked listserve users 
whether medical writers or editors 
were involved in any of the papers 
recently retracted for misconduct. 
This is a perfectly reasonable question 
to ask and wouldn’t it be nice if our 
profession could point to some hard 
data to say that medical writers are 
rarely involved in papers retracted for 
misconduct? As it turns out, last year, 
before this question was posted on the 
listserve, we had begun to investigate 
this very issue!
 I’d like to share some of our origi-
nal research, as it demonstrates that 
medical communicators can inves-
tigate ethical issues and, in so doing, 
generate hard data that can be used 
to get more respect for our profes-
sion. We are doing our best to com-
municate the results of our research 
to audiences who may question the 
ethics of medical communicators. As 
such, we presented these data at the 
2009 International Congress on Peer 
Review and Biomedical Publication 
hosted by JAMA and the British 
Medical Journal and attended by many 
of the world’s most influential jour-
nal editors and keen journalists. Our 
project was just profiled in Nature 
Medicine 2 and we have been invited to 
submit a commentary on our results 
to Lancet.
 Our research project was titled 
“Round Up the Usual Suspects? 
Involvement of Medical Writers 
and the Pharmaceutical Industry 
in Publications Retracted for 
Misconduct.” Integrity in the litera-
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ture is shot when misconduct occurs. 
Are the usual suspects really the most 
suspect? And who are the usual sus-
pects? If you believe Mr McHenry, 
you believe that “…it is now fairly well 
known that pharmaceutical compa-
nies launder their promotional efforts 
through medical communication 
companies that ghostwrite articles 
and then pay ‘key opinion leaders’…to 
affix their signatures to the fraudu-
lent articles…”3 Despite Mr McHenry’s 
dogmatic assertion and opinions, we 
thought we might conduct the larg-
est study done to date on retracted 
publications to 1. determine, for the 
first time, the proportion of retracted 
publications, especially those retracted 
for misconduct, that involved declared 
medical writers or pharmaceutical 
industry sponsorship, and 2. inves-
tigate factors that may be associated 
with misconduct retractions. I think 
Mr McHenry and others might be 
shocked to find out who is and who 
isn’t involved in retracted publica-
tions.
 Our results showed that the first 
group, which comprised those papers 
that had declared medical writing 
and industry support (ie, probably 
the most suspicious papers in some 
quarters) actually accounted for very 
few retractions and none of the mis-
conduct retractions (Figure 1). Even 
the second and third groups, which 
comprised papers where there was 
declared medical writing or declared 
industry support, accounted for very 
few retractions. The fourth group, 
where there was no declared indus-
try funding, accounted for almost all 
of the retractions and the miscon-
duct retractions. You have to ask why 
medical writers and the industry are 
guilty until proven innocent? These 
data should help our profession get 
more respect as they indicate that a 
paper that has declared medical writ-
ing involvement and industry support 
is unlikely to have to be retracted.  
Declaration of a medical writer on a 
paper should be seen as a good sign, 
not a bad sign.
 This conclusion is supported by 
the odds ratio data, where we looked 
at the odds of a paper being retracted 
for misconduct vs mistake. Mistake 
retractions served as the control 
group. The odds of being retracted for 
misconduct were significantly lower 
(less than 1.0) if medical writers or 
the pharmaceutical industry were 
involved, but were significantly  
higher (greater than 1.0) if the paper 
involved 
•	 A	single	author
•	 A	first	author	who	had	at	least	1	
other retraction (we now have evi-
dence to support the concept of the 
serial offender)
•	 A	first	author	who	was	affiliated	
with a low- or middle-income  
country  
 I think these results show that 
if a professional medical writer is 
involved in preparing a manuscript, 
a journal editor may be far less likely 
to go through the pain of having to 
retract a publication. So that is what 
we have done to investigate and pro-
mote ethics in our profession. What 
can you do?
 You too can be a pioneer and 
investigate the value and ethics of 
our profession. 
The importance of 
investigating and 
publishing research 
on our profession 
was eloquently 
stated by AMWA’s 
Mary Royer and 
Doug Haneline in 
a recent issue of 
the AMWA Journal: 
“The solution to 
making our profes-
sion and our work 
visible is not only 
more effective pub-
lic relations; it is 
a matter of estab-
lishing our iden-
tity and credibility 
through published 
research.” 4 They 
say that you should 
put your money 
where your mouth 
is, and on that note 
I am delighted to be partnering with 
some AMWA legends, Art Gertel and 
Nancy Taylor, to kickstart funding for 
the AMWA Award for Best Published 
Research.
 Importantly, we need medical 
writing publications in peer-reviewed 
journals listed in Medline so many 
other people can find them and read 
them—we can’t keep publishing 
our work in newsletters only. Please 
know that I am not asking you to do 
the impossible; it is challenging, yes, 
but we have managed to publish our 
papers on medical writing issues in 
high-ranking journals such as JAMA, 
Chest, and PLoS Medicine. Gaining 
and publishing evidence on our value 
and ethics can be done. We need to do 
it more.
 If you don’t think you can become 
a pioneer right now, though, you can 
certainly do your bit right now by sup-
porting the pioneers, particularly if 
you work on manuscripts. That means 
you need to be familiar with 
•	 the	AMWA	Position	Statement1
•	 Good	Publication	Practice	for	
Pharmaceutical Companies5
•	 the	Uniform	Requirements	
figure 1. Percentage of retractions among 4 groups of journal articles: 
those with declared medical writing and industry support, those with 
declared medical writing support, those with declared industry sup-
port, and those with no industry support. Reprinted, with permission, 
from Woolley KL, Woolley MJ, Lew RA, et al., Round up the usual sus-
pects? Involvement of medical writers and the pharmaceutical indus-
try in retracted publications. Paper presented at the Sixth Internation-
al Congress on Peer Review and Biomedical Publications; September 
10-12, 2009; Vancouver, Canada. http://www.ama-assn.org/public/
peer/abstracts_2009.html#113. Accessed November 11, 2009.
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for Manuscripts Submitted to 
Biomedical Journals (www.icmje.
org)
 And, you simply must reject ghost-
writing work—ghostwriters must be 
stopped—their short-term financial 
gain causes us long-term professional 
pain! 
 The survey recently completed 
by Adam Jacobs from the European 
Medical Writers Association (EMWA) 
and Cindy Hamilton, your AMWA 
2008-2009 President, showed that 
EMWA and AMWA members are  
doing less ghostwriting.6 However, 
I was staggered to see that 42% of 
EMWA and AMWA members are still 
ghostwriting! This is just not good 
enough!! It is simply not acceptable 
that 42% of AMWA and EMWA mem-
bers are still ghostwriting, and keep  
in mind that this 42% is likely to 
underestimate the true problem, 
given that these medical writers have 
at least recognized the importance of 
joining a professional association.  
 Lastly, when it comes to declaring 
your involvement and funding source, 
I encourage you to urge your authors 
to use the checklist that we recently 
published in PLoS Medicine.7 This 
checklist was designed by medical 
writers in Europe, North America, and 
the Asia/Pacific region. Importantly, 
the checklist is freely available, with-
out any copyright restrictions, from 
PLoS Medicine (one of the highest 
ranking journals in general medicine) 
and on the EQUATOR network Web 
site (www.equator-network.org). The 
checklist is the only tool that gives 
editors “teeth” at minimal cost to 
them. Please get your authors to use 
it! If you do, we will create an interna-
tional groundswell of submissions to 
editors that show just how ready pro-
fessional medical writers and authors 
are to prove that they are working 
together ethically.
New froNtiers of MedicAl 
coMMuNicAtioN
Our second challenge relates to the 
new frontiers of medical communica-
tion. To address this challenge, I put 
to you that we need to we need to take 
a truly international approach to our 
expectations and our education of 
medical communicators. Respect for 
our profession cannot be piecemeal; 
our profession is international and we 
are only as strong as our weakest link. 
We can’t have people say, “Oh yes, I 
respect medical communicators in 
this country, but not that country.” 
Our challenges are international, and 
our solutions must be international; 
as medical communicators, are all in 
this together.  
 Don’t say there weren’t warning 
signs about how critical this challenge 
could get. Earlier here, I highlighted 
that retractions from low- and middle-
income countries were of particular 
concern. The so-called worst of the 
worst of these countries are China, 
Croatia, Egypt, India, Lebanon, and 
South Africa. These countries not only 
had the highest number of retractions 
but also had the highest number of 
retractions for misconduct. The coun-
tries that should ring alarm bells are 
India and China, as clinical trials are 
surging there (almost doubling in the 
past 3 years). How many of you or your 
organizations have a risk manage-
ment strategy in place to deal with the 
significantly higher odds of a miscon-
duct retraction coming from these 
countries? You can bet that investiga-
tors in these countries will want to 
author papers. I want to stress that we 
can’t punish innocent authors from 
these countries, but thinking that 
retractions from these countries will 
suddenly disappear is ignorant and 
irresponsible. 
 Some of you may be thinking that 
all this trouble over there doesn’t 
affect you. If it doesn’t now, it may 
in the future unless our profession 
acts. Market research indicates that 
the global medical writing market is 
growing; it has apparently doubled 
in last 5 years.8 Market research also 
indicates that about 40% of clients are 
outsourcing their medical writing.8 
Quite simply, our profession is grow-
ing and it is going global. This is good 
news, but we have to realize that this 
also increases the risk that medical 
writers around the world may not be 
have the value and ethics that would 
help our profession gain respect. We 
must realize that poorly trained medi-
cal writers anywhere—from Dallas to 
Delhi—affect all of us; they can add  
to or detract from respect for our pro-
fession. 
 So what can we as a profession do? 
I put to you that because our profes-
sion is working in new frontiers, we 
need a new certificate, and I think an 
organization like AMWA would be one 
of the best organizations to offer this 
new certificate. First, I want to com-
pare the AMWA core certificate with 
the certificate that I propose AMWA 
offers, namely an international cer-
tificate. I offer this comparison not to 
criticize the existing core certificate; 
rather, I don’t think the core cer-
tificate is suitable for international 
medical writers in terms of content, 
delivery, and time. And I think our 
profession needs a certificate that is 
suitable with regard to these factors. 
In terms of content, the core certifi-
cate requires 8 modules and ethics 
is not compulsory; I would make the 
international certificate require only 
4 modules and make ethics compul-
sory. In terms of delivery, the core 
certificate offers most of its modules 
in person; I would make the interna-
tional certificate all online. It does 
not matter where in the world you are, 
you could do the AMWA international 
certificate. In terms of time, the core 
certificate would probably take some-
one from India or Australia or else-
where in the world 3 years to do and 
that depends on if they could do their 
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modules at the AMWA conference and 
if they could afford the travel and time 
costs to attend the AMWA conference 
for 3 years. I would make the interna-
tional certificate program possible to 
complete in 1 year.
 Why would AMWA offer an inter-
national certificate? What are the 
benefits for AMWA? First, if AMWA 
stepped into the gap in the market, 
it could reinforce AMWA as a leader 
in its field; other organizations might 
offer basic training, even certifica-
tion in medical communication, but 
they don’t have the history or reputa-
tion of AMWA. Second, AMWA could 
build this certificate for minimal 
cost by leveraging content from its 
existing modules, and the certificate 
could be a new source of revenue, as 
well as a new source of new mem-
bers. Third, the certificate would help 
AMWA raise its profile internationally. 
Importantly, AMWA would not have 
to deliver this international certificate 
on its own if it did not want to. AMWA 
could partner with other organiza-
tions, such as the soon-to-be-formed 
Asia-Pacific Medical Writing Group, to 
offer this certificate to international 
members.
 In addition to the international 
certificate, I also think our profes-
sion should start using a new tool 
that identifies the knowledge, skills, 
and behaviors we expect of a medi-
cal writer, no matter where in the 
world that medical writer might come 
from. David Clemow and I worked 
with medical writers in Europe, North 
America, and the Asia/Pacific region 
to develop a medical writer compe-
tency model. For the past year, the 
line managers at our company have 
piloted the use of this competency 
model to hire and train medical writ-
ers, and the results have been very 
positive indeed. You will be able to 
read more about this competency 
model when David and I publish an 
article on the model soon and I will 
speak with AMWA about making this 
model, designed by medical writers 
for medical writers, freely available to 
interested AMWA members.
 In the interim though, what can 
you do? I encourage you to discuss 
the proposal of AMWA developing an 
international medical writing cer-
tificate; if AMWA doesn’t, then who 
should? There is no time to waste on 
this—we need to make sure that med-
ical writers around the world have a 
very basic, but very clear, understand-
ing of the value and ethics expected 
of medical writers. I also encourage 
you to be active professionals—if and 
when you liaise with medical writ-
ers overseas, encourage them to join 
AMWA and take every opportunity 
you can to reinforce how important 
ethics are to our profession. Lastly,  
I encourage you to trial the compe-
tency model when it becomes avail-
able to you.  
the loNesoMe PositioN of 
MedicAl coMMuNicAtors
Our third challenge relates to the 
often lonesome position of medical 
communicators. To address this chal-
lenge, we need to be much more pro-
active and strategic in how we interact 
with those who need to understand 
the value and ethics of professional 
medical writers. Essentially, we have 
to find our rightful place—where we 
belong and where we are respected. 
Medical communicators must interact 
with many stakeholders if we want to 
take more steps forward for our pro-
fession; I will just focus on 2 groups: 
editors and the media.
 If we really want to interact with 
editors in a respectful and meaning-
ful way, we have to appreciate their 
concerns. In the eyes of many edi-
tors, we have a negative history. They 
don’t necessarily know the difference 
between professional medical writ-
ers and ghostwriters, but they sure 
know that ghostwriters are bad. They 
don’t want to embroil their journal 
in ghostwriting controversy and end 
up on the front page of The New York 
Times or The Wall Street Journal for all 
the wrong reasons. You can under-
stand, perhaps, why some editors just 
want to ban all writers. There is also 
confusion about which organization 
journal editors should consult about 
a medical writing issue. Should they 
go to AMWA, or EMWA, or the Drug 
Information Association (DIA), or 
the International Society for Medical 
Publication Professionals (ISMPP) 
or the Association of Regulatory and 
Clinical Scientists in Australia (ARCS) 
or the All India Medical Writers 
Association or…the list could go on.  
When editors need a credible, clear, 
and quick answer on medical writers, 
who is their “go to” contact?  
 I want to highlight to you that if we 
do interact with editors, in a respect-
ful and meaningful manner, there is 
the possibility of gaining more respect 
for our profession. For example, you 
may have been aware that the Clinical 
Journal of Oncology Nursing previously 
had a policy that “banned articles 
written by writers as a way to avoid 
ghostwriting.”9 After a few of us inter-
acted with the editor of this journal, 
particularly after we had published 
our article about medical writers in 
PLoS Medicine7 (note that this was a 
journal that another editor had actu-
ally read), the policy was changed.10 
In addition to changing the policy, 
the editor also kindly published cor-
respondence from AMWA legend Art 
Gertel and me, which as you might 
guess, focused on the value and ethics 
of professional medical writers.11,12
 What about interacting with the 
media? First, I think it is important to 
highlight, as evident in a quote from 
the New England Journal of Medicine, 
that at least some people in the media 
are realizing that they must hold 
themselves to higher standards. Susan 
Dentzer wrote, “We in the news media 
have a responsibility to hold ourselves 
to higher standards...we must be more 
than carnival barkers; we must be...
more interested in...[communicating] 
than carrying out our other agen-
das.”13 From reading many articles in 
the media, you would think that there 
has been an agenda to get rid of medi-
cal writers. Indeed, many of these 
articles would have readers believe 
that all medical writers are bad; there 
never seem to be any good apples.
 I appreciate that interacting with 
the media is not always easy or advis-
able, particularly when they might 
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corner you in bathroom, as the jour-
nalist from The Wall Street Journal did 
to me one day in Chicago, or corner 
you on the telephone trying to trap 
you into saying that your clients force 
you to ghostwrite, as the journal-
ist from the British Medical Journal 
tried to do to me last year. He was not 
successful—we don’t ghostwrite and 
we never will. I gave him a simple 
message, but it was not the one on his 
agenda.
 So what can you do when it comes 
to interacting with editors and the 
media? One thing you can do, and 
which too many medical commu-
nicators don’t do, is to use the right 
words. Whenever you speak with an 
editor or the media (or anyone else for 
that matter), never say that you are a 
ghostwriter (I am assuming here that 
you aren’t!). Instead, say that you are 
a professional medical writer. Explain 
the difference. If it helps, you can refer 
them to my article in Chest, which 
reinforces that professional medical 
writers are not the same as ghostwrit-
ers.14 We, of all people, should know 
how powerful words are…let’s all start 
using the right words when we inter-
act with others. 
 Also, if AMWA agrees, you could 
be quite proactive in your local chap-
ter. For example:
•	 You	could	identify	just	1	editor	or	
journalist in your region.
•	 You	could	then	send	them	a	copy	of	
AMWA’s Position Statement.
•	 You	could	set	up	an	interview	with	
an AMWA spokesperson (some-
one who has strong knowledge and 
media training).
•	 You	could	invite	the	editor	or	jour-
nalist to attend the annual confer-
ence and have a dedicated person 
available to show them around—
one look at the AMWA conference 
program and they would see how 
strong AMWA is on ethics and 
value.
•	 You	could	then	build	on	these	
relationships—sending out useful 
press releases—fortunately, AMWA 
already has a very helpful publicity 
kit to get you on your way.
 Now if you or someone in your 
chapter doesn’t take these steps,  
who will?
 What can we, as a profession, 
do? I think we have to change how 
our profession interacts with editors 
and journalists. Currently, an issue 
breaks and, quite rightly, a whole 
bunch of associations or individu-
als respond to that issue. Not surpris-
ingly, this can create confusion, as 
our profession has a splintered voice. I 
believe our profession needs a united 
voice, and I put to you that we estab-
lish an International Committee of 
Professional Medical Writers, mod-
elled somewhat on the lean, but highly 
influential, International Committee 
of Medical Journal Editors (ICMJE). 
This committee would allow for 
•	 A	credible	response—the	commit-
tee would be made up of highly 
respected representatives from 
professional medical writing asso-
ciations around the world; it would 
not compete with our existing 
associations, it would complement 
them.
•	 A	clear	response—we	could	speak	
with a unified and international 
voice.
•	 A	quick	response—the	committee	
would be the initial “go to” contact, 
with responses provided within 
24-48 hours.
 With such a committee, we could 
have a much simpler way of respond-
ing to an issue; further, this commit-
tee could also be used to raise issues 
of concern to our professional asso-
ciations. If we build trust with editors 
and journalists, the relationship can 
be two-way. If ICMJE can do all that it 
has without large costs, why can’t we?
 This keynote is drawing to a close 
and I promised you that by the end of 
this presentation you would be able 
to say “yes” to 2 questions. So let me 
summarize what we and you can do 
to help our profession address the 3 
challenges I identified and get more 
respect.
1. Our first challenge is to investigate 
our value and our ethics.
I have suggested that as a profes-
sion, we could encourage and fund 
research; the AMWA Award for Best 
Published Research did not exist last 
year, but with starting funds from 
3 medical writers and support from 
AMWA, we now have that in place.  
 I have suggested that you could 
help by
•	 Winning	the	award—why	not	be	
rewarded if you publish research 
on the value or ethics of medical 
writers?
•	 Knowing	the	rules	that	govern	
what we do and reject ghostwriting 
work; we simply have to get  
that 42% down to less than 1%.
•	 Using	the	medical	writer	checklist	
published in PLoS Medicine; this 
checklist is free and readily  
available. 
2. Our second challenge is to address 
our new frontiers. 
We need to take a truly international 
approach to our expectations and 
education of medical writers. I have 
suggested that as a profession, we 
could develop an international certifi-
cate and a medical writer competency 
model. We have the model already 
and I believe we can and should work 
toward the certificate.
 I have suggested that you could 
help by
•	 Debating	whether	AMWA	should	
offer an international certificate.
•	 Promoting	ethical	practices	and	
AMWA to your international  
colleagues.
•	 Trialing	the	competency	model; 
I will work with AMWA to make it 
available to you when it is ready. 
Our profession is international and 
our core competencies should be  
as well.
3. Our third challenge is to not be so 
lonesome. 
I believe we need to interact more, 
and in better ways, with journal edi-
tors and the media. I have suggested 
that as a profession, we could estab-
lish an International Committee of 
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Professional Medical Writers; this 
might be controversial, but as we are 
not doing so well in our interactions 
right now, we need to do something 
different.
 I have suggested that you could 
help by
•	 Using	the	right	words—if	you	are	
a professional medical writer, you 
are certainly not a ghostwriter.
•	 Contacting	your	local	journalist	
or a medical journal editor; show 
that you appreciate their concerns 
and do what you can to help raise 
awareness of our value and our 
ethics; we need more respect from 
journalists and editors and you 
could do your bit to help.
 I hope I have been able to share 
with you what getting more respect 
for our profession means to me. I also 
hope that together, you and I and our 
medical communication colleagues 
around the world, can truly, as Aretha 
Franklin would say, “tcb”—an acro-
nym (and you know how much we 
all love acronyms) for “taking care of 
business.” Medical communication is 
our business; it is our profession, and 
we all need to take strong steps for-
ward to ensure our profession gets the 
respect it deserves.
Thank you.
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kAREN woollEy hAS My RESPEcT
By Debra Gordon, MS
First, a confession: I usually skip keynote addresses. I find 
such talks vague and rambling, designed, by necessity, to ap-
peal to the masses instead of focusing on a specific topic. So 
the main reason I was sitting in the third row of the ballroom 
during Karen Woolley’s keynote address in Dallas this year 
was because I had been asked to write a summary of the talk 
for the AMWA Journal. Then, when the decision was made to 
publish the address in its entirety, making my article redun-
dant, I was asked to write an analysis/opinion piece on it. 
 I knew this wasn’t going to be your typical keynote 
address when the sounds of Aretha Franklin’s “Respect” 
boomed through the hall. In its wake came this lovely Aus-
tralian with a pixie cut and an accent I could happily listen 
to all day. Then came her slides—creative, funny, and to the 
point. Whoa, I thought, this is a woman who knows how to 
give a compelling talk.
 And what a talk! I hope that you’ve read her talk, so I’m 
not going to get into the details here. Instead, let me tell you 
how her talk affected me.  
 For most of my career, I’ve written about health and 
medicine for consumers. I have thousands of articles and 
at least a dozen books with my name on them. But I’ve also 
Karen Woolley was the recipient of an honorary AMWA fellow-
ship, which was presented to her by Faith Reidenbach, ELS (left), 
and Marianne Mallia, ELS (right), at the Sablack Awards dinner.
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Karen Woolley’s keynote address was packed with practical tips for 
AMWA members. I encourage you to download the audio file and 
slides from the Members Only section of AMWA’s Web site. While 
you’re there, search for relevant information that dovetails with 
Dr Woolley’s advice. For example, she encouraged us to perform 
research to document the value we add to medical communication; 
the Web site has information on AMWA’s new awards on published 
research (www.amwa.org/default.asp?id=467) and student research 
(www.amwa.org/default.asp?id=468). Karen also urged AMWA 
members to reject ghostwriting assignments; take the time to review 
AMWA’s recently expanded ethics section of the Web site (www.
amwa.org/default.asp?id=471). Following Karen’s advice will help 
medical communicators gain respect both for themselves and the 
profession.
—Cindy W. Hamilton, PharmD, ELS
2008-2009 AMWA President
By showcasing her own leadership (along with that of several peers) 
in conducting research on ethical practices in medical writing and 
publications, Dr Woolley outlined a map for getting the medical writ-
ing profession from “here” to “there.” Our current situation (“here”) 
is characterized by an underappreciation and mischaracterization 
of our role in the support, development, and polishing of medical 
and research publications. The goal for our profession (“there”) is to 
achieve respect and recognized legitimacy in the collaborative effort 
that comprises modern scientific research. Not only must we dem-
onstrate our value (ie, measurable contributions in terms of time/
resource savings and improved outcomes) but we must let there be 
no doubt that we operate under unified, well-defined, and indisput-
able ethical principles. There is much work to do in this regard, espe-
cially because recent research still shows that unethical ghostwriting 
practices are still occurring (though at markedly decreased levels 
than seen in the past). Dr Woolley’s mantra to those who ghostwrite 
medical publications, “Your short-term gain causes us all long-term 
pain,” is as much a call to action as it is an admonition—we must 
only accept and undertake work that will be conducted ethically 
with appropriate acknowledgment of nonauthor contributions and 
potential conflicts of interest. Not doing so will perpetuate a cycle 
of distrust, increased scrutiny, and perhaps the eventual ruin of an 
honorable, yet widely unrecognized, profession.
—Tom Gegeny, MS, ELS
2009-2010 AMWA President
Karen Woolley’s keynote address at the 2009 annual conference 
raises important issues about the role of medical writers—and 
AMWA—in scientific communications. Dr Woolley shows us that the 
high road to new global respect for the value and integrity of medical 
communicators is paved with research, evidence, and collabora-
tion with our brothers and sisters in related associations around the 
world. By working together to establish proof of our value and integ-
rity, we earn can respect as professional medical communicators.   
—Sue Hudson
2007-2008 AMWA President
AMWA MeMbers CoMMent on the Keynote Address
written a few trade books for doctors under their 
name. In other words, I have, yes, ghostwritten. Not 
only that, but in the publishing world, ghostwrit-
ers are not only in high demand but we’re actually 
proud of what we do. One of my closest friends 
commands 6 figures for every book she pens. Her e-
mail signature proclaims that she is the “co-author 
and ghostwriter of 6 NY Times bestsellers.”
 Can you imagine a medical writer putting that 
on his or her sig?
 All of this is a very roundabout way of saying 
that until Dr Woolley’s talk, I really hadn’t worried 
all that much about my own role in the ghost-
writing debate. Although my work had gradually 
transitioned over the years from 100% consumer to 
about half consumer, half scientific, the few papers 
I’d worked on for publication in journals had, to my 
knowledge, acknowledged me. One even listed me 
as a coauthor. But I hadn’t really pushed for it or 
made it a priority when negotiating jobs. 
 That has now changed. In fact, the week I 
returned from the AMWA conference, I received an 
assignment to help with a review article. The first 
thing I did (after trying to get more money) was ask 
about credit. Of course, said the project manager. 
No problem. 
 Bottom line: Dr Woolley’s talk energized me. 
It made me really understand the ramifications 
of the ghostwriting issue beyond the yelling and 
misinformation in the media (and, occasionally, on 
our listserve). Why? Her research. Dr Woolley’s work 
clearly demonstrated that medical writers are not 
the problem when it comes to questionable publi-
cations. Which, as she clearly pointed out, begs the 
question: How do we get that message out to the 
broader public?
 One thing I loved about Dr Woolley’s talk was 
that she didn’t just throw that question out there 
but provided a very specific, point-by-point plan 
to address the problem, something I wish more 
speakers/experts would do. Although I know there 
was a lot of debate about her recommendations, I 
have to say (because this is opinion and I’m allowed 
to) that I thought they were brilliant. I support 
every one. 
 Dr Karen Woolley has provided us with the road 
map to respect for our profession, but she cannot 
singlehandedly lead us to our destination. Instead, 
it is up to us, the rank-and-file of AMWA, to gas 
up the car, choose the best routes, and avoid the 
roadblocks if we are to convince the broader world 
of our worth and contributions and address the 
rumors and misinformation currently cluttering 
this highway. 
